Moreover, given that TNF-α contributes to progression of several cancers [46], reducing TNF-α levels in AML using MMP inhibitors may dampen the inflammatory milieu in the BM microenvironment; however further studies are required to confirm it. This evidence concerns the gene TNF and acute myeloid leukemia.